SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms

by Adcock, M., Anderson, S., Bordin, N., Dallago, C., Ho, B.K, Kaur, S., O’Donoghue, S.I, Procter, J.B, Rost, B., Schafferhans, A., Sikta, N., Stolte, C.
Published 2021

Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection

by Gao, X., Huang, H., Ma, C., Peng, H., Ren, H., Su, Y., Zhang, B., Zhou, L.
Published 2021

Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs

by Nair, D.T, Narayanan, N.
Published 2021

Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants

by Gowthaman, R., Guest, J.D, Mittra, I., Pierce, B.G, Quackenbush, J., Taherzadeh, G., Yin, R.
Published 2021

Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections

by King, S.B, Singh, M.
Published 2021

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

by Karakaş, N., Karaoğlan, B.S, Öztürk, G., Shah, K., Üçüncüoğlu, S., Uludağ, D.
Published 2022

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

by Bluhm, A.P, Grodzki, M., Karst, S.M, Norris, M.H, Rafiee, R., Russo, M., Schaefer, M., Sobh, A., Tagmount, A., Vulpe, C.D
Published 2022

Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development

by Brogi, A., Castria, M., Cerutti, H., Ricci, V., Soldatini, C., Tesi, G., Toppi, S., Tornesi, S., Vaccaro, M.N, Verdiani, S.
Published 2021

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective

by Baldwin, J., Honda-Okubo, Y., Li, L., Petrovsky, N., Piplani, S., Sakala, I.G
Published 2021

Simple, Inexpensive RNA Isolation and One-Step RT-qPCR Methods for SARS-CoV-2 Detection and General Use

by Dailey, G.M, Darzacq, X., Dugast-Darzacq, C., Graham, T.G.W, Tjian, R.
Published 2021

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

by Alsaadawe, M., Chen, X., Chen, Z., Disoma, C., Dong, Z., Du, A., Hu, L., Jiang, T., Li, S., Li, S., Li, S., Liu, P., Liu, S., Mo, L., Peng, J., Peng, Y., Razzaq, A., Shen, Y., Xia, Z., Yang, Q., Zhang, Q., Zhang, Y., Zheng, R., Zhou, Y.
Published 2021